Literature DB >> 8691459

Alkyl and alkoxyethyl antineoplastic phospholipids.

M Koufaki1, V Polychroniou, T Calogeropoulou, A Tsotinis, M Drees, H H Fiebig, S LeClerc, H R Hendriks, A Makriyannis.   

Abstract

Two series of phosphodiester ether lipid analogs with (N-methylmorpholino)ethyl or (N-methylpiperidino)ethyl polar head groups and long aliphatic or alkoxyethyl chains in the nonpolar portion of the molecule were synthesized as potential antineoplastic agents. The cytotoxic activity of these compounds (9-19) was evaluated in vitro against a panel of six human tumor xenografts and in two biochemical, mechanism-based screens (cdc2 kinase and cdc25 phosphatase). Analogs 13, 14, 17, and 19 showed activity in the in vitro tests. Specifically, 14 and 17 were more active than the reference compound hexadecylphosphocholine (Miltefosine, He-PC) while 13 and 19 possessed activity similar to that of the control. Of the analogs tested the one with the highest potency and least toxicity (17) has an N-methylpiperidino head group and a C16 alkyl chain. In the mechanism-based tests 11 showed weak inhibitory activity in the cdc25 phosphatase screen.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8691459     DOI: 10.1021/jm9509152

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  1 in total

Review 1.  Cdc25 as a potential target of anticancer agents.

Authors:  J W Eckstein
Journal:  Invest New Drugs       Date:  2000-05       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.